{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:49:57Z","timestamp":1783345797085,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T00:00:00Z","timestamp":1400284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6882-14-159","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T19:01:22Z","timestamp":1400353282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Yves","family":"Henrotin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Dierckxsens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Priem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelin","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Heuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Castermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,17]]},"reference":[{"key":"1740_CR1","first-page":"244","volume":"66","author":"J Samuels","year":"2008","unstructured":"Samuels J, Krasnokutsky S, Abramson SB: Osteoarthritis: a tale of three tissues. Bull NYU Hosp Jt Dis. 2008, 66: 244-250.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"1740_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/ard.2004.028886","volume":"64","author":"W Zhang","year":"2005","unstructured":"Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M: EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005, 64: 669-681. 10.1136\/ard.2004.028886.","journal-title":"Ann Rheum Dis"},{"key":"1740_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P: OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008, 16: 137-162. 10.1016\/j.joca.2007.12.013.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","volume":"15","author":"W Zhang","year":"2007","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P: OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007, 15: 981-1000. 10.1016\/j.joca.2007.06.014.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P: OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010, 18: 476-499. 10.1016\/j.joca.2010.01.013.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M: EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003, 62: 1145-1155. 10.1136\/ard.2003.011742.","journal-title":"Ann Rheum Dis"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/ar2016","volume":"8","author":"LG Ameye","year":"2006","unstructured":"Ameye LG, Chee WS: Osteoarthritis and nutrition: from nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006, 8: R127-10.1186\/ar2016.","journal-title":"Arthritis Res Ther"},{"key":"1740_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.joca.2010.10.017","volume":"19","author":"Y Henrotin","year":"2011","unstructured":"Henrotin Y, Lambert C, Couchourel D, Ripoll C, Chiotelli E: Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis Cartilage. 2011, 19: 1-21. 10.1016\/j.joca.2010.10.017.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR9","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1208\/ps050325","volume":"5","author":"EK Kalra","year":"2003","unstructured":"Kalra EK: Nutraceutical\u2013definition and introduction. AAPS PharmSci. 2003, 5: E25-","journal-title":"AAPS PharmSci"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.joca.2009.10.002","volume":"18","author":"Y Henrotin","year":"2010","unstructured":"Henrotin Y, Clutterbuck AL, Allaway D, Lodwig EM, Harris P, Mathy-Hartert M, Shakibaei M, Mobasheri A: Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 2010, 18: 141-149. 10.1016\/j.joca.2009.10.002.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmed.2012.01.004","volume":"18","author":"L Shen","year":"2012","unstructured":"Shen L, Ji HF: The pharmacology of curcumin: is it the degradation products?. Trends Mol Med. 2012, 18: 138-144. 10.1016\/j.molmed.2012.01.004.","journal-title":"Trends Mol Med"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/01635581.2010.509835","volume":"62","author":"A Goel","year":"2010","unstructured":"Goel A, Aggarwal BB: Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer. 2010, 62: 919-930. 10.1080\/01635581.2010.509835.","journal-title":"Nutr Cancer"},{"key":"1740_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mnfr.200700354","volume":"52","author":"A Goel","year":"2008","unstructured":"Goel A, Jhurani S, Aggarwal BB: Multi-targeted therapy by curcumin: how spicy is it?. Mol Nutr Food Res. 2008, 52: 1010-1030. 10.1002\/mnfr.200700354.","journal-title":"Mol Nutr Food Res"},{"key":"1740_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB: Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol. 2008, 75: 787-809. 10.1016\/j.bcp.2007.08.016.","journal-title":"Biochem Pharmacol"},{"key":"1740_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev.nutr.012809.104755","volume":"30","author":"BB Aggarwal","year":"2010","unstructured":"Aggarwal BB: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010, 30: 173-199. 10.1146\/annurev.nutr.012809.104755.","journal-title":"Annu Rev Nutr"},{"key":"1740_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009, 41: 40-59. 10.1016\/j.biocel.2008.06.010.","journal-title":"Int J Biochem Cell Biol"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","volume":"30","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Sung B: Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009, 30: 85-94. 10.1016\/j.tips.2008.11.002.","journal-title":"Trends Pharmacol Sci"},{"key":"1740_CR18","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.3390\/molecules16064567","volume":"16","author":"P Basnet","year":"2011","unstructured":"Basnet P, Skalko-Basnet N: Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011, 16: 4567-4598. 10.3390\/molecules16064567.","journal-title":"Molecules"},{"key":"1740_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2193-1801-2-56","volume":"2","author":"Y Henrotin","year":"2013","unstructured":"Henrotin Y, Priem F, Mobasheri A: Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus. 2013, 2: 56-10.1186\/2193-1801-2-56.","journal-title":"Springerplus"},{"issue":"11","key":"1740_CR20","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"B Chandran","year":"2012","unstructured":"Chandran B, Goel A: A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012, 26 (11): 1719-1725. 10.1002\/ptr.4639.","journal-title":"Phytother Res"},{"key":"1740_CR21","first-page":"337","volume":"15","author":"G Belcaro","year":"2010","unstructured":"Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G: Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010, 15: 337-344.","journal-title":"Altern Med Rev"},{"key":"1740_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.joca.2010.08.019","volume":"19","author":"VB Kraus","year":"2011","unstructured":"Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, Gardiner J, Garnero P, Hardin J, Henrotin Y, Heinegard D, Ko A, Lohmander LS, Matthews G, Menetski J, Moskowitz R, Persiani S, Poole AR, Rousseau JC, Todman M: Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011, 19: 515-542. 10.1016\/j.joca.2010.08.019.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/BOR.0b013e32829fb3b5","volume":"19","author":"Y Henrotin","year":"2007","unstructured":"Henrotin Y, Addison S, Kraus V, Deberg M: Type II collagen markers in osteoarthritis: what do they indicate?. Curr Opin Rheumatol. 2007, 19: 444-450. 10.1097\/BOR.0b013e32829fb3b5.","journal-title":"Curr Opin Rheumatol"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M: Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee: diagnostic and therapeutic criteria committee of the american rheumatism association. Arthritis Rheum. 1986, 29: 1039-1049. 10.1002\/art.1780290816.","journal-title":"Arthritis Rheum"},{"key":"1740_CR25","first-page":"543","volume":"41","author":"Y Henrotin","year":"2004","unstructured":"Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY: Type II collagen peptides for measuring cartilage degradation. Biorheology. 2004, 41: 543-547.","journal-title":"Biorheology"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/art.34392","volume":"64","author":"Y Henrotin","year":"2012","unstructured":"Henrotin Y, Gharbi M, Mazzucchelli G, Dubuc JE, De Pauw E, Deberg M: Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum. 2012, 64: 2260-2267. 10.1002\/art.34392.","journal-title":"Arthritis Rheum"},{"key":"1740_CR27","first-page":"36","volume":"22","author":"S Christgau","year":"2004","unstructured":"Christgau S, Henrotin Y, Tanko LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY: Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin Exp Rheumatol. 2004, 22: 36-42.","journal-title":"Clin Exp Rheumatol"},{"key":"1740_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.12688\/f1000research.2-147.v1","volume":"2","author":"AL Clutterbuck","year":"2013","unstructured":"Clutterbuck AL, Allaway D, Harris P, Mobasheri A: Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1beta-treated articular cartilage. F1000Res. 2013, 2: 147-","journal-title":"F1000Res"},{"key":"1740_CR29","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/ar3065","volume":"12","author":"C Buhrmann","year":"2010","unstructured":"Buhrmann C, Mobasheri A, Matis U, Shakibaei M: Curcumin mediated suppression of nuclear factor-kappaB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther. 2010, 12: R127-10.1186\/ar3065.","journal-title":"Arthritis Res Ther"},{"key":"1740_CR30","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/bph.12131","volume":"169","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal BB, Gupta SC, Sung B: Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013, 169: 1672-1692. 10.1111\/bph.12131.","journal-title":"Br J Pharmacol"},{"key":"1740_CR31","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1002\/art.22875","volume":"56","author":"LG Ameye","year":"2007","unstructured":"Ameye LG, Deberg M, Oliveira M, Labasse A, Aeschlimann JM, Henrotin Y: The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis Rheum. 2007, 56: 3336-3346. 10.1002\/art.22875.","journal-title":"Arthritis Rheum"},{"key":"1740_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.joca.2012.03.016","volume":"20","author":"Y Henrotin","year":"2012","unstructured":"Henrotin Y, Martel-Pelletier J, Msika P, Guillou GB, Deberg M: Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO2, in the anterior cruciate ligament OA canine model. Osteoarthritis Cartilage. 2012, 20: 787-790. 10.1016\/j.joca.2012.03.016.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.joca.2009.09.011","volume":"18","author":"JL Huebner","year":"2010","unstructured":"Huebner JL, Williams JM, Deberg M, Henrotin Y, Kraus VB: Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis. Osteoarthritis Cartilage. 2010, 18: 397-405. 10.1016\/j.joca.2009.09.011.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11259-011-9487-5","volume":"35","author":"DR Verwilghen","year":"2011","unstructured":"Verwilghen DR, Martens A, Busschers E, Franck T, Deberg M, Henrotin Y, Vanderheyden L, Serteyn D: Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Vet Res Commun. 2011, 35: 401-408. 10.1007\/s11259-011-9487-5.","journal-title":"Vet Res Commun"},{"key":"1740_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/ard.2007.073452","volume":"67","author":"M Deberg","year":"2008","unstructured":"Deberg M, Dubuc JE, Labasse A, Sanchez C, Quettier E, Bosseloir A, Crielaard JM, Henrotin Y: One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement. Ann Rheum Dis. 2008, 67: 168-174. 10.1136\/ard.2007.073452.","journal-title":"Ann Rheum Dis"},{"key":"1740_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.joca.2004.12.002","volume":"13","author":"M Deberg","year":"2005","unstructured":"Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, Zegels B, Reginster JY, Henrotin Y: New serum biochemical markers (Coll 2\u20131 and Coll 2\u20131 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2005, 13: 258-265. 10.1016\/j.joca.2004.12.002.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/jor.22297","volume":"31","author":"Y Henrotin","year":"2013","unstructured":"Henrotin Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D, Maillet B, Rannou F, Piroth C, Mathieu P, Rannou F, Conrozier T: Early decrease of serum biomarkers of type II collagen degradation (Coll2\u20131) and joint inflammation (Coll2\u20131 NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: A research study part of the Biovisco study. J Orthop Res. 2013, 31: 901-907. 10.1002\/jor.22297.","journal-title":"J Orthop Res"},{"key":"1740_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/2193-1801-2-92","volume":"2","author":"Y Henrotin","year":"2013","unstructured":"Henrotin Y, Labasse A, Franck T, Bosseloir A, Bury T, Deberg M: Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. Springerplus. 2013, 2: 92-10.1186\/2193-1801-2-92.","journal-title":"Springerplus"},{"key":"1740_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.joca.2012.02.638","volume":"20","author":"L Punzi","year":"2012","unstructured":"Punzi L, Ramonda R, Deberg M, Frallonardo P, Campana C, Musacchio E, Henrotin Y: Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis Cartilage. 2012, 20: 557-561. 10.1016\/j.joca.2012.02.638.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR40","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bcp.2007.01.005","volume":"73","author":"M Shakibaei","year":"2007","unstructured":"Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A: Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007, 73: 1434-1445. 10.1016\/j.bcp.2007.01.005.","journal-title":"Biochem Pharmacol"},{"key":"1740_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","volume":"13","author":"X Ayral","year":"2005","unstructured":"Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M: Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis \u2013 results of a 1\u00a0year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005, 13: 361-367. 10.1016\/j.joca.2005.01.005.","journal-title":"Osteoarthritis Cartilage"},{"key":"1740_CR42","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1136\/ard.2011.150243","volume":"70","author":"FW Roemer","year":"2011","unstructured":"Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, Lynch JA, Lewis CE, Torner J, Zhang Y: Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis. 2011, 70: 1804-1809. 10.1136\/ard.2011.150243.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-14-159\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T20:44:04Z","timestamp":1548103444000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-14-159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,17]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-14-159","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,17]]},"assertion":[{"value":"5 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"159"}}